68 Pulmonary Embolism Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting Pulmonary Embolism Studies in Chicago

NCT04774159Recruiting

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular ...

Chicago, ILPHASE36,150 participantsPopulation Health Research Institute

View Study Details

NCT05390892Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...

Chicago, ILPHASE46,000 participantsBrigham and Women's Hospital

View Study Details

NCT06676904Recruiting

Neonatal Platelet Transfusion Threshold Trial

The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshol...

Chicago, ILNA2,433 participantsNICHD Neonatal Research Network

View Study Details

NCT06989775Recruiting

BoxX-NoAF Clinical Trial

Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients...

Chicago, ILNA960 participantsAtriCure, Inc.

View Study Details

NCT06911632Recruiting

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk ...

Chicago, ILNA900 participantsTempus AI

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Chicago, IL750 participantsBoston Children's Hospital

View Study Details

NCT06220721Recruiting

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfun...

Chicago, ILNA618 participantsMedical College of Wisconsin

View Study Details

NCT03849443Recruiting

Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery

As tranexamic acid (TXA) becomes more prevalent, all patients are receiving the same dose and method of delivery regardless of their pre-operative risk of transfusion. Therefore, the aim of the study ...

Chicago, ILEARLY_PHASE1604 participantsRush University Medical Center

View Study Details

NCT07288398Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with p...

Chicago, ILPHASE3540 participantsTenax Therapeutics, Inc.

View Study Details

NCT06433011Recruiting

The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

To demonstrate the efficacy and safety of the 8F BASHIR™ .035 Endovascular Catheter and the 8F BASHIR™ S-B .035 Endovascular Catheter for the administration of pharmaco-mechanical catheter directed th...

Chicago, ILNA500 participantsThrombolex, Inc.

View Study Details

NCT06686121Recruiting

Improving Mobility After Revascularization in Peripheral Artery Disease

Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ische...

Chicago, ILPHASE3386 participantsNorthwestern University

View Study Details

NCT02332668Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cance...

Chicago, ILPHASE1370 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07285655Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by interstitial lung disease (PH-ILD, WHO Group 3)...

Chicago, ILPHASE3344 participantsLiquidia Technologies, Inc.

View Study Details

NCT06274801Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study...

Chicago, ILPHASE3330 participantsGB002, Inc.

View Study Details

NCT07010159Recruiting

Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis....

Chicago, ILPHASE2325 participantsKiniksa Pharmaceuticals International, plc

View Study Details

NCT06740383Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bi...

Chicago, IL320 participantsBeth Israel Deaconess Medical Center

View Study Details

NCT06560619Recruiting

Mindfulness, Exercise, and Nutrition To Optimize Resilience (MENTOR)

The Mindfulness, Nutrition and Exercise to Optimize Resilience (MENTOR) program is offered through the National Center on Health, Physical Activity and Disability (NCHPAD). NCHPAD is funded by the Cen...

Chicago, ILNA300 participantsShirley Ryan AbilityLab

View Study Details

NCT07676565Recruiting

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will e...

Chicago, IL300 participantsIndiana University

View Study Details

NCT07218016Recruiting

Accelerometer Measured Early Recovery After Prolapse Surgery

The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-reported recovery questionnaire completed...

Chicago, ILNA288 participantsNICHD Pelvic Floor Disorders Network

View Study Details

NCT05309746Recruiting

Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

The purpose of this study is to safely remove ovarian tissue in pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and h...

Chicago, IL250 participantsErin Rowell

View Study Details

NCT06971939Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

The purpose of this global, multicenter, open-label, Phase 4 clinical extension study is to evaluate the long-term safety and efficacy of revakinagene taroretcel-lwey (Encelto™; hereinafter referred t...

Chicago, ILPHASE4234 participantsNeurotech Pharmaceuticals

View Study Details

NCT02780297Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and aden...

Chicago, IL220 participantsMayo Clinic

View Study Details

NCT04228978Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk dis...

Chicago, ILNA212 participantsNorthwestern University

View Study Details

NCT06032065Recruiting

SMART Exercise for PAD

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lowe...

Chicago, ILPHASE3210 participantsNorthwestern University

View Study Details

NCT06952738Recruiting

Investigating Periprosthetic Fracture Cultures in Arthroplasty

This study aims to improve how doctors diagnose infections in patients with broken bones around joint replacements. Currently, there are no clear guidelines to help determine when an infection is pres...

Chicago, IL200 participantsUniversity of Chicago

View Study Details

NCT06657976Recruiting

Response to Exercise and Nitric Oxide in PAD

RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether ex...

Chicago, ILPHASE2200 participantsNorthwestern University

View Study Details

NCT07579702Recruiting

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glyce...

Chicago, ILNA200 participantsInsulet Corporation

View Study Details

NCT07547345Recruiting

Mobilizing Community Hypertension Access Pilot

The Live Healthy Chicago (LHC) Community Pilot is a prospective, community-based study evaluating the feasibility, effectiveness, and economic impact of a pharmacist-led hypertension management progra...

Chicago, ILNA200 participantsRush University Medical Center

View Study Details

NCT07293689Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing d...

Chicago, IL200 participantsNorthwestern University

View Study Details

NCT02305654Recruiting

International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)

This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a series of questions that routinely arise in the sequencing of t...

Chicago, ILPHASE3200 participantsInstitute of Cancer Research, United Kingdom

View Study Details

NCT06899750Recruiting

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hype...

Chicago, ILNA200 participantsRush University Medical Center

View Study Details

NCT06481904Recruiting

Registry for Stage 2 Type 1 Diabetes

Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyper...

Chicago, IL200 participantsSanofi

View Study Details

NCT04794530Recruiting

The COCOA-PAD II Trial

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...

Chicago, ILPHASE3190 participantsNorthwestern University

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

Chicago, ILPHASE2165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT06217302Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

Chicago, ILPHASE3150 participantsAlessandro Doria

View Study Details

NCT04592445Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes peo...

Chicago, ILNA150 participantsAxon Therapies, Inc.

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Chicago, ILPHASE1135 participantsChimeric Therapeutics

View Study Details

NCT06224218Recruiting

Prostate Single Port & Laser Enucleation Comparison Trial

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open ...

Chicago, ILNA116 participantsUniversity of Illinois at Chicago

View Study Details

NCT06708299Recruiting

CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation

Multi-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, schedule...

Chicago, ILPHASE3110 participantsCardiol Therapeutics Inc.

View Study Details

NCT06466161Recruiting

Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients

The diagnosis of hypertensive disease during pregnancy is predicated on strict blood pressure thresholds: 140/90 on at least two occasions measured four hours apart for both gestational hypertension a...

Chicago, ILNA110 participantsNorthwestern University

View Study Details

NCT05208164Recruiting

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

The proposed research and training will allow Dr. Alana Biggers to obtain critical research skills and study a mindfulness meditation program designed to improve sleep and reduce stress in African-Ame...

Chicago, ILNA100 participantsUniversity of Illinois at Chicago

View Study Details

NCT06624046Recruiting

Circadian Mechanisms, Glucose, and CV Risks in T1D

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep...

Chicago, ILNA100 participantsUniversity of Illinois at Chicago

View Study Details

NCT06555952Recruiting

MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaN...

Chicago, ILNA80 participantsClinical Nutrition Research Center, Illinois Institute of Technology

View Study Details

NCT05866562Recruiting

Dupilumab in the Treatment of Pediatric Alopecia Areata

This is a prospective, randomized, double-blind, placebo-controlled clinical trial. The study will take place at four sites. This trial will enroll a total of 76 children and adolescents with moderate...

Chicago, ILPHASE276 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06544499Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...

Chicago, ILPHASE369 participantsargenx

View Study Details

NCT05001880Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal me...

Chicago, ILPHASE266 participantsNational Cancer Institute (NCI)

View Study Details

NCT06057935Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal m...

Chicago, ILPHASE264 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

Chicago, ILPHASE352 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06836232Recruiting

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Recurrent Pericarditis (RP). Approximately 30 patients will take VTX2735. The study consists of a ...

Chicago, ILPHASE250 participantsZomagen Biosciences Ltd.

View Study Details

NCT06401356Recruiting

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

The purpose of this study is to evaluate the long-term safety and the clinical benefit of pelabresib in patients with hematological and/or solid tumor indications or advanced malignancies. Additionall...

Chicago, ILPHASE350 participantsNovartis Pharmaceuticals

View Study Details

NCT07610655Recruiting

Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression

This study will examine whether noninvasive, transcutaneous vagal nerve stimulation (tcVNS) can help restore consciousness in patients in the operating room and the Post Anesthesia Care Unit (PACU). T...

Chicago, ILNA40 participantsNorthwestern University

View Study Details

NCT05879250Recruiting

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

This phase II trial tests how well the combination of WP1066 and radiation therapy works in treating newly diagnosed glioblastoma. Glioblastoma is difficult to treat effectively because the cells with...

Chicago, ILPHASE239 participantsNorthwestern University

View Study Details

NCT05705024Recruiting

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of...

Chicago, ILPHASE238 participantsUniversity of Illinois at Chicago

View Study Details

NCT06399809Recruiting

Fisetin to Reduce Senescence and Mobility Impairment in PAD

The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutane...

Chicago, ILPHASE234 participantsNorthwestern University

View Study Details

NCT06410248Recruiting

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

This phase I trial tests the safety, side effects, and best dose of triapine in combination with temozolomide in treating patients with glioblastoma that has come back after a period of improvement (r...

Chicago, ILPHASE130 participantsNorthwestern University

View Study Details

NCT06327477Recruiting

Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma

This phase I/II trial studies the side effects and best dose of proton-spatially fractionated radiotherapy (P-SFRT) and to see how well it works with standard radiation therapy in treating patients wi...

Chicago, ILPHASE128 participantsNorthwestern University

View Study Details

NCT06712875Recruiting

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Pediatric gliomas harboring BRAF-alterations, commonly BRAFV600 mutation or KIAA1549-BRAF fusion, are currently treated with either chemotherapy or mitogen activated protein kinase (MAPK) inhibitors, ...

Chicago, ILPHASE127 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

Chicago, ILPHASE225 participantsHealx Limited

View Study Details

NCT07650682Recruiting

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

This observational study aims to collect detailed metabolic and physiologic data from adults with insulin-dependent type 2 diabetes mellitus following consumption of a mixed meal tolerance test. Parti...

Chicago, IL25 participantsClinical Nutrition Research Center, Illinois Institute of Technology

View Study Details

NCT06504914Recruiting

Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors

Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibilit...

Chicago, ILNA24 participantsUniversity of Illinois at Chicago

View Study Details

NCT06919081Recruiting

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

In this phase II randomized double-masked clinical trials, subjects with non-resolving corneal epithelial disease/defect (i.e., refractory to standard treatments for at least two weeks) will receive 8...

Chicago, ILPHASE224 participantsUniversity of Illinois at Chicago

View Study Details

NCT04796012Recruiting

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

This trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in children with relapsed/r...

Chicago, ILPHASE123 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05145374Recruiting

Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress

The objective of this proposal is to demonstrate a viable, functionally integrated multivariable artificial pancreas (mvAP) that will address meal, physical activity (PA) and acute psychological stres...

Chicago, IL20 participantsUniversity of Illinois at Chicago

View Study Details

NCT06989008Recruiting

Enhancing Diabetes Care: Exposome &Amp; Sensors

The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study ...

Chicago, IL20 participantsUniversity of Illinois at Chicago

View Study Details

NCT01630850Recruiting

Islet Transplantation in Patients With "Brittle" Type I Diabetes

The purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. I...

Chicago, ILNA20 participantsUniversity of Chicago

View Study Details

NCT06881992Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor-Associated Hyperinsulinism

The objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug for treatment of hypoglycemia in patients with Tumor-Associated Hyperinsulinism (tHI)....

Chicago, ILPHASE316 participantsRezolute

View Study Details

NCT06950593Recruiting

Transcutaneous Electrical Stimulation for Stroke Patients

This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It...

Chicago, ILNA14 participantsShirley Ryan AbilityLab

View Study Details

NCT06560762Recruiting

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)...

Chicago, ILPHASE112 participantsSecretome Therapeutics

View Study Details

About Pulmonary Embolism Clinical Trials in Chicago

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 68 pulmonary embolism clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 27,436 participants. Research is being sponsored by Population Health Research Institute, Brigham and Women's Hospital, NICHD Neonatal Research Network and 42 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Chicago — FAQ

Are there pulmonary embolism clinical trials in Chicago?

Yes, there are 68 pulmonary embolism clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 68 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated August 30, 2026 from ClinicalTrials.gov